They plan to run similar trials on seven more patients over the next three years, backed by $4 million from the National ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

A trial has shown boosting diet with supplements could halt tumour growth in prostate cancer patients - opening the door to a ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

A new cancer treatment that uses light could remove the need for harsh chemotherapy or radiotherapy. Texas researchers have devised a way to use infrared light as a jackhammer that can tear cancer ...

French scientists work on a cancer vaccine, one of several in development that raises hopes of coming breakthroughs - Copyright AFP Abdul MAJEED French scientists ...

A breast cancer drug already on the market has been found to lower the chances of breast cancer recurring, an advancement that could open the drug to a broader range of patients. The pharmaceutical ...